CRISPR2 Trademark Information

Trademark by KSQ Therapeutics, Inc.

Drug discovery services; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: Not provided
First Use In Commerce: Not provided
General Information
Word mark: CRISPR2
Status/Status Date:
FIRST EXTENSION - GRANTED
3/25/2021
Serial Number: 88765574
Filing Date: 1/20/2020
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Drug discovery services; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields
Mark Description: The mark consists of the letters "CRISPR" followed by the numeral "2" in superscript.
Type Of Mark: Service Mark
Published For Opposition Date: 8/11/2020
Last Applicant/Owner:
KSQ Therapeutics, Inc.
Cambridge, MA 02139
Mark Drawing Code: Drawing with Words in Stylized form
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Womble Bond Dickinson (US) LLP
470 Atlantic Ave., Suite 600
Boston MA 02210-2228
Current Status:
FIRST EXTENSION - GRANTED
3/25/2021
Correspondent Search:
TIMOTHY H. HIEBERT is a correspondent of CRISPR2 trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on